Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1474-2026Class II

Campy CVA Medium 100/PK, R01272

Remel Inc / initiated 2026-02-05 / Open, Classified

Remel, Inc began a recall of Campy CVA Medium 100/PK, R01272 on . FDA classified it as Class II and gives the reason as "Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium". As of , the recall status on record is Open, Classified.

Recall record

Recall number
Z-1474-2026
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Remel Inc
Product
Campy CVA Medium 100/PK, R01272
Product code
JSJ Culture Media, Selective And Non-Differential
Reason for recall
Customer complaints report low to no recovery of Campylobacter Jejuni ATCC 33291 on identified lot of medium.
FDA root cause
Under Investigation by firm
Action
On February 5, 2026, the firm notified affected customers via Urgent Medical Device Recall letter. Customers were instructed to review test results and destroy any remaining inventory of the affected lot.
Quantity in commerce
97
Distribution
US Nationwide distribution in the states of AZ, CO, IL, NJ, OH, TN, WA.
Product codes and lots
UDI-DI 848838001055 Lot R01272 lot 339135 Expired January 12, 2026

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1474-2026
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1474-2026Class IIOngoingVoluntary: Firm initiated